Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Puerto Rico Technology Today.
Press releases published on September 11, 2025
EIN Presswire Unveils First Case Study on Using Press Releases to Increase AI Search Visibility and Media Coverage
How My Home Pathway leveraged EIN Presswire to expand reach, enhance AI search visibility, and build media momentum. WASHINGTON , DC, UNITED STATES, September 11, 2025 /EINPresswire.com/ -- It’s no secret that people are increasingly using artificial …
Geotab Surpasses 5 Million Global Connected Vehicle Subscriptions
SYDNEY, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Geotab Inc. (“Geotab”), today announced it has achieved a new company milestone, surpassing 5 million connected vehicle subscriptions worldwide. This rapid growth, with the last million subscriptions added in less …
Correction: Next Technology Holding Inc. Announces Reverse Stock Split
CHEYENNE, Wyoming, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Next Technology Holding Inc. (“NXTT” or the “Company”) (NASDAQ: NXTT), a technology firm committed to delivering AI-enabled software development services and strategic Bitcoin acquisition, announced …
ESET Shares CISO Perspectives and Priorities in MSP Summit Keynote
SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- ESET, a global leader in cybersecurity, today announced that its Field CISO Charles “Chuck” Everette will deliver a keynote “From the CISO’s Desk: Redefining MSP Partnerships in Today’s Threat Landscape” at the …
Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer
SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for treatment of …
Roivant Named on Fortune Media and Great Place To Work’s 2025 Best Workplaces in BioPharma List
BASEL, Switzerland and LONDON and NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Great Place To Work® and Fortune magazine have selected Roivant (Nasdaq: ROIV) for the 2025 Fortune Best Workplaces in BioPharma™ List. This is Roivant’s first time being named …
San Antonio JCE SEO Digital Marketing Agency Nears 20 Years in Business
JCE SEO Celebrates Nearly Two Decades of Digital Marketing Excellence in San Antonio Family-founded agency expands services in SEO, web design, and digital advertising while strengthening support for Texas businesses San Antonio, TX , Sept. 11, 2025 (GLOBE …
NurExone Biologic Announces Corporate Updates including Israel Patent Grant and Private Placement Closing
TORONTO and HAIFA, Israel, Sept. 11, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a pioneering biopharmaceutical company developing exosome-based regenerative therapies, is pleased to …
Dianthus Therapeutics, Inc. Announces Closing of its Upsized $288 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
NEW YORK and WALTHAM, Mass., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune …
Energous Announces Closing of Registered Direct Offering and Concurrent Warrant Exercise for $5 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
SAN JOSE, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Energous Corporation d/b/a Energous Wireless Power Solutions (Nasdaq: WATT) (“Energous” or the “Company”), a pioneer in scalable, over-the-air (OTA) wireless power networks, today announced the closing …
Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
BOSTON and SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
IBEX Reports Strongest Quarterly Growth Rate in Nearly 3 Years, Record Fiscal Year 2025 Financial Results, Introduces Fiscal Year 2026 Guidance
Record fourth quarter and full-year Revenue, EPS, Adjusted EPS, and Free Cash Flow Fourth quarter revenue grew 18.2% versus prior year quarter, and full-year revenue grew 9.8% Fourth quarter EPS of $0.66 and adjusted EPS of $0.87 grew 19% and 50%, …
Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option
CHICAGO and FORT WORTH, Texas, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult …
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Company announcement – No. 20 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, September 11, 2025 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a …
Next Technology Holding Inc. Announces Reverse Stock Split
CHEYENNE, Wyoming, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Next Technology Holding Inc. (“NXTT” or the “Company”) (NASDAQ: NXTT), a technology firm committed to delivering AI-enabled software development services and strategic Bitcoin acquisition, announced …
Alonaw Business School Celebrates Five-Year Milestone with Record Enrollment in AI-Enhanced Investment Course
Denver, Colorado,, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Alonaw Business School commemorates five years of investment education excellence as its fifth annual course series achieves record-breaking enrollment, reflecting growing demand for AI-integrated …
Recludix Pharma to Present at the Stifel 2025 Virtual Immunology and Inflammation Forum
SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that Nancy Whiting, Pharm.D., president and chief executive officer, Ajay Nirula, M.D., …
Lipomax Drops Official Launch 2025: Himalayan Pink Salt Trick Weight Management Formula Explained
New York City, NY, Sept. 11, 2025 (GLOBE NEWSWIRE) -- An Independent, In-Depth Analysis “Lipomax Drops”? Lipomax Drops have officially launched in 2025, marking their entry into the liquid weight-management supplement category. This comprehensive guide …
Sarat Ventures Y Innovations Biotech Fund investiert in Start-up-Unternehmen mit Schwerpunkt auf Saudi-Arabien und der MENA-Region
LONDON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- In einem historischen Schritt zur Positionierung Saudi-Arabiens als globaler Knotenpunkt für Biotechnologie gab Sarat Ventures Y Innovations Biotech Fund (UK) heute die Auflegung eines Biotech-Fonds bekannt, der …
Le fonds Sarat Ventures Y Innovations Biotech Fund prévoit d’investir dans des entreprises en phase de démarrage, plus particulièrement en Arabie saoudite et dans la région MENA
LONDRES, 11 sept. 2025 (GLOBE NEWSWIRE) -- Dans le cadre d’une initiative historique visant à positionner l’Arabie saoudite comme un pôle mondial de la biotechnologie, le fonds Sarat Ventures Y Innovations Biotech Fund (Royaume-Uni) a annoncé aujourd’hui …